Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: A prospective study

Lancet Oncology

Volumn 7, Issue 3, 2006, Pages 211-222

  Meimarakis, Georgios ^a   Winter, Hauke ^a   Assmann, Ilka ^a   Kopp, Reinhard ^a   Lehn, Norbert ^b   Kist, Manfred ^c   Stolte, Manfred ^d   Jauch, Kalter Walter ^a   Hatz, Rudolf A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d INSTITUTE OF PATHOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CISPLATIN; EOSIN; FLUOROURACIL; FOLINIC ACID; HEMATOXYLIN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEX DIFFERENCE; STOMACH CARCINOMA; STOMACH SURGERY;

ADENOCARCINOMA; AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33344470407     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70586-1     Document Type: Article

References (46)

1. P Lauren The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 1965 31-49
2. BJ Marshall JR Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311-1315
3. International Agency for Research on Cancer Infection with Helicobacter pylori IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori Volume 61 1994 IARC Lyon 177-244
4. MS Wu HW Hung JT Wang et al. Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features Hepatogastroenterology 45 1998 2432-2436
5. WJ Lee JT Lin CT Shun et al. Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori Br J Surg 82 1995 802-805
6. WJ Lee JT Lin WC Lee et al. Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomas J Clin Gastroenterol 21 1995 203-207
7. MF Dixon RM Genta JH Yardley P Correa Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994 Am J Surg Pathol 20 1996 1161-1181
8. RA Hatz N Lehn S Leyh et al. Prevalence of Helicobacter pylori infection in stomach carcinoma Chirurg 67 1996 403-408
9. I Takeda S Ine N Killeen et al. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells J Immunol 172 2004 3580-3589
10. B Valzasina C Guiducci H Dislich et al. Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: A novel regulatory role for OX40 and its comparison with GITR Blood 105 2005 2845-2851
11. E Bayerdorffer H Oertel N Lehn et al. Topographic association between active gastritis and Campylobacter pylori colonisation J Clin Pathol 42 1989 834-839
12. Y Yonemura I Ninomiya A Yamaguchi et al. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer Cancer Res 51 1991 1034-1038
13. Y Yonemura Y Endo H Fujita et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer Clin Cancer Res 5 1999 1823-1829
14. H Saito S Tsujitani A Kondo et al. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma Surgery 125 1999 195-201
15. M Mori K Mimori T Shiraishi et al. Analysis of MT1-MMP and MMP2 expression in human gastric cancers Int J Cancer 74 1997 316-321
16. H Allgayer R Babic KU Grutzner et al. An immunohistochemical assessment of cathepsin D in gastric carcinoma: Its impact on clinical prognosis Cancer 80 1997 179-187
17. MM Heiss R Babic H Allgayer et al. The prognostic impact of the urokinase-type plasminogen activator system is associated with tumor differentiation in gastric cancer Eur J Surg Oncol 22 1996 74-77
18. JR Siewert R Kestlmeier R Busch et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases Br J Surg 83 1996 1144-1147
19. Y Kodera Y Yamamura Y Shimizu et al. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection J Surg Oncol 72 1999 60-64
20. D Bentrem A Wilton M Mazumdar et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection Ann Surg Oncol 12 2005 347-353
21. M Haraguchi A Watanabe S Moriguchi et al. DNA ploidy is a major prognostic factor in advanced gastric carcinoma - univariate and multivariate analysis Surgery 110 1991 814-819
22. JJ Bonenkamp J Hermans M Sasako et al. for the Dutch Gastric Cancer Group Extended lymph-node dissection for gastric cancer N Engl J Med 340 1999 908-914
23. A Cuschieri S Weeden J Fielding et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group Br J Cancer 79 1999 1522-1530
24. M Tachibana Y Takemoto Y Nakashima et al. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer J Am Coll Surg 187 1998 64-68
25. M Kochi M Fujii N Kanamori et al. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer Gastric Cancer 3 2000 177-186
26. D Korenaga H Saeki K Mawatari et al. Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma Arch Surg 132 1997 188-194
27. M Ychou J Duffour A Kramer et al. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer Dis Markers 16 2000 105-110
28. A Tocchi G Costa L Lepre et al. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer J Cancer Res Clin Oncol 124 1998 450-455
29. S Kikuchi Epidemiology of Helicobacter pylori and gastric cancer Gastric Cancer 5 2002 6-15
30. K Murakami M Kodama R Sato et al. Helicobacter pylori eradication and associated changes in the gastric mucosa Expert Rev Anti Infect Ther 3 2005 757-764
31. P Blok ME Craanen GJ Offerhaus et al. Molecular alterations in early gastric carcinomas. No apparent correlation with Helicobacter pylori status Am J Clin Pathol 111 1999 241-247
32. JJ Kim H Tao E Carloni et al. Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells Gastroenterology 123 2002 542-553
33. NR dos Santos R Seruca M Constancia et al. Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis Gastroenterology 110 1996 38-44
34. MS Wu CW Lee CT Shun et al. Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer Cancer Res 58 1998 1494-1497
35. WK Leung JJ Kim JG Kim et al. Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer Am J Pathol 156 2000 537-543
36. JD Hayden L Cawkwell MF Dixon et al. A comparison of microsatellite instability in early onset gastric carcinomas from relatively low and high incidence European populations Int J Cancer 85 2000 189-191
37. JT Lin MS Wu CT Shun et al. Microsatellite instability in gastric carcinoma with special references to histopathology and cancer stages Eur J Cancer 31A 1995 1879-1882
38. J Garay JC Bravo P Correa BG Schneider Infrequency of microsatellite instability in complete and incomplete gastric intestinal metaplasia Hum Pathol 35 2004 102-106
39. MS Wu CW Lee JC Sheu et al. Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis Hepatogastroenterology 49 2002 285-289
40. A Mattsson H Lonroth M Quiding-Jarbrink AM Svennerholm Induction of B cell responses in the stomach of Helicobacter pylori-infected subjects after oral cholera vaccination J Clin Invest 102 1998 51-56
41. KB Bamford X Fan SE Crowe et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype Gastroenterology 114 1998 482-492
42. MA Gavin SR Clarke E Negrou A Rudensky Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo Nat Immunol 3 2002 33-41
43. S Malett S Fossum AN Barclay Characterization of the MRC OX40 antigen of activated CD4 positive T-lymphocytes EMBO J 9 1990 1063-1068
44. PR Baum Gayle RB 3rd F Ramsdell et al. Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34 EMBO J 13 1994 3992-4001
45. WR Godfrey FF Fagnoni MA Harara et al. Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor Exp Med 180 1994 757-762
46. DJ Paterson WA Jefferies JR Green et al. Antigens of activated rat T lymphocytes including a molecule of 50 000 Mr detected only on CD4 positive T blasts Mol Immunol 24 1987 1281-1290